Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Kezar Life Sciences (KZR) Leases (2021 - 2025)

Kezar Life Sciences' Leases history spans 5 years, with the latest figure at $1.0 million for Q3 2025.

  • For Q3 2025, Leases fell 51.0% year-over-year to $1.0 million; the TTM value through Sep 2025 reached $1.0 million, down 51.0%, while the annual FY2024 figure was $1.9 million, 60.53% down from the prior year.
  • Leases for Q3 2025 was $1.0 million at Kezar Life Sciences, down from $1.3 million in the prior quarter.
  • Across five years, Leases topped out at $9.7 million in Q4 2022 and bottomed at $1.0 million in Q3 2025.
  • The 5-year median for Leases is $2.7 million (2021), against an average of $3.9 million.
  • The largest annual shift saw Leases soared 268.25% in 2023 before it crashed 73.45% in 2024.
  • A 5-year view of Leases shows it stood at $2.7 million in 2021, then skyrocketed by 258.92% to $9.7 million in 2022, then crashed by 50.95% to $4.8 million in 2023, then tumbled by 60.53% to $1.9 million in 2024, then plummeted by 44.33% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for KZR's Leases are $1.0 million (Q3 2025), $1.3 million (Q2 2025), and $1.6 million (Q1 2025).